Candel Therapeutics Inc. Made Big Gain

Fri, Oct 21, 2022 at 07:32 PM

Candel Therapeutics Inc. (CADL:NASDAQ) jumped higher at $1.8, a gain of 21.6%. From Fri, Oct 07, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days

About Candel Therapeutics Inc. (CADL:NASDAQ)

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Top 10 Gainers:

Huadi International Group Co. Ltd. (HUDI:NASDAQ), 89.27%
Altamira Therapeutics Ltd. (CYTO:NASDAQ), 58.64%
Missfresh Limited (MF:NASDAQ), 57.5%
Enservco Corporation (ENSV:NYSEMKT), 37.42%
Renovare Environmental Inc. (RENO:NASDAQ), 33.33%
Kaleyra Inc. (KLR:NYSE), 24.85%
Veris Residential Inc. (VRE:NYSE), 23.27%
Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 22.15%
Candel Therapeutics Inc. (CADL:NASDAQ), 21.62%
Energy Focus, Inc. (EFOI:NASDAQ), 21.47%